NGL Fine-Chem (BOM:524774) Margin of Safety % (DCF Dividends Based): N/A (As of Jul. 27, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BOM:524774 NGL Fine-Chem Ltd BOM:524774
69 GF Score
Price ₹3,194.85
GF Value ₹2,868.91
Valuation Modestly Overvalued
! 8 Warning Signs
View Full Analysis

What is NGL Fine-Chem Margin of Safety % (DCF Dividends Based)?

Margin of Safety % (DCF Dividends Based) = (Intrinsic Value: DCF (Dividends Based) - Current Price) / Intrinsic Value: DCF (Dividends Based).

Note: Discounted Dividend model is only suitable for companies who have a consistant distribution history with more than 5 years. If the company's dividends does not remain steady over a long period, results may not be accurate due to the low consistency. The model is also only suitable for predictable companies (Business Predictability Rank higher than 1-Star). If the company's Predictability Rank is 1-Star or Not Rated, the data will not be stored into our database.

NGL Fine-Chem's Predictability Rank is 1-Star. Thus, the DCF related results in the screener and portfolio will appear as zero and Margin of Safety % (DCF Dividends Based) is not calculated.

BOM:524774 vs LLY, JNJ, ABBV: Margin of Safety % (DCF Dividends Based) Comparison

For the Drug Manufacturers - General subindustry, NGL Fine-Chem's Margin of Safety % (DCF Dividends Based), along with its competitors' market caps and Margin of Safety % (DCF Dividends Based) data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

NGL Fine-Chem Margin of Safety % (DCF Dividends Based) vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, NGL Fine-Chem's Margin of Safety % (DCF Dividends Based) distribution charts can be found below:

* The bar in red indicates where NGL Fine-Chem's Margin of Safety % (DCF Dividends Based) falls into.


BOM:524774
69GF Score
NGL Fine-Chem Ltd BOM:524774
Margin of Safety % (DCF Dividends Based) is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is NGL Fine-Chem (BOM:524774) Overvalued in 2026?

Based on GuruFocus' analysis, NGL Fine-Chem stock appears to be overvalued. The current stock price of ₹3,194.85 is trading 11.4% above its estimated GF Value™ of ₹2,868.91. GuruFocus considers NGL Fine-Chem to be Modestly Overvalued.

Key valuation signals for BOM:524774:

  • Margin of Safety % (DCF Dividends Based): N/A
  • GF Value™: ₹2,868.91 vs. price of ₹3,194.85 (11.4% above fair value)
  • GF Score™: 69/100 with 8 warning signs

No single metric tells the full story. See the BOM:524774 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

NGL Fine-Chem Business Description

Other Exchanges NGLFINE:India
Address 301, E Square, Subhash Road, Vile Parle (East), Mumbai, MH, IND, 400057
NGL Fine-Chem Ltd is an Indian company engaged in the pharmaceutical business. It is a manufacturer of pharmaceuticals and intermediates for use in veterinary and human health, catering to various companies to custom-manufacture pharmaceuticals. The company's product portfolio comprises animal health APIs such as homidium chloride, nitroxynil, clorsulon, decoquinate, fenbendazole, etc.; human health APIs such as nitazoxanide and atovaquone; drug intermediates and specialty chemicals; and finished dosage forms such as diminazene aceturate granules and homidium chloride tablets. Geographically, the group generates maximum revenue from the Asia-Pacific region, and the rest from India, Europe, the USA, and the rest of the world.
69GF Score

Get the complete analysis for BOM:524774

Margin of Safety % (DCF Dividends Based) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹3,194.85
Price
₹2,868.91
GF Value